1. Home
  2. GKOS vs MNSO Comparison

GKOS vs MNSO Comparison

Compare GKOS & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$120.64

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo MINISO Group Holding Limited

MNSO

MINISO Group Holding Limited

HOLD

Current Price

$19.32

Market Cap

6.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GKOS
MNSO
Founded
1998
2013
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Department/Specialty Retail Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
6.0B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
GKOS
MNSO
Price
$120.64
$19.32
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
2
Target Price
$127.71
$24.10
AVG Volume (30 Days)
677.3K
427.5K
Earning Date
02-17-2026
11-20-2025
Dividend Yield
N/A
3.20%
EPS Growth
N/A
N/A
EPS
N/A
0.98
Revenue
$469,820,000.00
$2,795,603,723.00
Revenue This Year
$31.33
$27.54
Revenue Next Year
$24.01
$19.30
P/E Ratio
N/A
$19.71
Revenue Growth
30.38
23.44
52 Week Low
$73.16
$13.95
52 Week High
$163.71
$26.74

Technical Indicators

Market Signals
Indicator
GKOS
MNSO
Relative Strength Index (RSI) 64.15 44.52
Support Level $93.96 $19.52
Resistance Level $115.00 $19.84
Average True Range (ATR) 4.48 0.35
MACD -0.42 0.04
Stochastic Oscillator 94.40 32.02

Price Performance

Historical Comparison
GKOS
MNSO

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About MNSO MINISO Group Holding Limited

MINISO Group Holding Ltd is a value retailer offering a variety of trendy lifestyle products featuring IP design. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying, and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying, and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: